Meclofenamate Sodium

甲氯芬那酸钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMeclofenamate Sodium
Drug Alias Name甲氯灭酸钠甲氯灭酸钠盐甲氯胺苯酸钠MeclodolMeclomen +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPainDysmenorrheaOsteoarthritis +[4] 
Global Approved IndicationsPainDysmenorrheaOsteoarthritis +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1980/06/25
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParke Davis Pharmaceutical Research Div Warner Lambert Co
Active IndicationsN/A
Inactive IndicationsPainDysmenorrheaOsteoarthritis +[4] 

Other Information

ATC CodeM01AG04M02AA18
Related LinksWikipediaDrugBankKEGG